文献速递心境障碍焦虑、强迫与应激相关障碍

正念团体治疗对抑郁、焦虑、压力及适应障碍患者的经济学评价:与常规治疗比较

Economic evaluation of mindfulness group therapy for patients with depression, anxiety, stress and adjustment disorders compared with treatment as usual.
PubMed 文献 · Br J Psychiatry · 2020-01-01

基于一项在瑞典开展的随机对照试验(NCT01476371),该研究从医疗保健和社会视角对正念团体治疗(MGT)与常规治疗(主要为认知行为治疗)进行成本-效果分析,试验时长8周。MGT组医疗保健和社会成本均显著低于对照组(平均差分别为-€115和-€112),而QALY增益无显著差异(平均差-0.003)。结论认为MGT在试验期间是节省成本的替代方案。

要点

  • MGT组医疗保健成本平均低€115(95%CI -193至-36),社会成本平均低€112(95%CI -207至-17)。
  • 两组QALY增益无显著差异(平均差-0.003,95%CI -0.0076至0.0012)。
  • 在8周试验期内,MGT相比常规治疗更具成本节省优势。

核心结论

  • 在试验时长8周内,从医疗保健和社会视角,MGT均是常规治疗的节省成本替代方案。

研究设计与样本

  • 基于一项随机对照试验的成本-效果分析,试验注册号NCT01476371,在瑞典开展,比较MGT与常规治疗(主要为认知行为治疗),分析时限为8周。

主要发现

  • MGT组医疗保健成本显著低于对照组,平均差-€115(95%CI -193至-36)。
  • MGT组社会成本显著低于对照组,平均差-€112(95%CI -207至-17)。
  • 两组QALY增益无显著差异,平均差-0.003(95%CI -0.0076至0.0012)。

关键数值与推荐

  • 效果测量采用EQ-5D-5L问卷和英国价值集计算QALY。
  • 不确定性通过非参数自举法(5000次重复)估计,并呈现95%置信区间和成本-效果可接受曲线。

临床怎么用

  • 对于抑郁、焦虑、压力及适应障碍患者,可考虑将结构化的正念团体治疗作为常规治疗的节省成本替代方案。

局限性

  • 分析时限仅为8周试验期间,未报告长期成本-效果。
  • 效果测量基于EQ-5D-5L和英国价值集,可能影响结果的外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A randomised controlled trial found that a structured mindfulness group therapy (MGT) programme was as effective as treatment as usual (mostly cognitive-behavioural therapy) for patients with a diagnosis of depression, anxiety or stress and adjustment disorders in Sweden (ClinicalTrials.gov: NCT01476371). AIMS: To perform a cost-effectiveness analysis of MGT compared with treatment as usual from both a healthcare and a societal perspective for the trial duration (8 weeks). METHOD: The costs from a healthcare perspective included treatment as usual, medication and costs for providing MGT. The societal perspective included costs from the healthcare perspective plus savings from productivity gains for the trial duration. The effectiveness was measured as quality-adjusted life-years (QALY) using the EQ-5D-5L questionnaire and the UK value set. Uncertainty surrounding the incremental costs and effects were estimated using non-parametric bootstrapping with 5000 replications and presented with 95% confidence intervals and cost-effectiveness acceptability curves. RESULTS: The MGT group had significantly lower healthcare and societal costs (mean differences -€115 (95% CI -193 to -36) and -€112 (95% CI -207 to -17), respectively) compared with the control group. In terms of effectiveness, there was no significant difference in QALY gain (mean difference -0.003, 95% CI -0.0076 to 0.0012) between the two groups. CONCLUSIONS: MGT is a cost-saving alternative to treatment as usual over the trial duration from both a healthcare and a societal perspective for patients with a diagnosis of depression, anxiety or stress and adjustment disorders in Sweden.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Saha S, Jarl J, Gerdtham UG, et al. Economic evaluation of mindfulness group therapy for patients with depression, anxiety, stress and adjustment disorders compared with treatment as usual. Br J Psychiatry. 2020. PMID: 30468136. doi:10.1192/bjp.2018.247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。